IP Library Granted Patent US 8,241,272
Granted Patent B2
US 8,241,272 · App. 11/481,204 · Granted Aug 14, 2012

Methods for ablation with radiant energy

Assignee: CardioFocus, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,241,272
App. No.
11/481,204
Granted
Aug 14, 2012
Kind
B2
Abstract

A method of treating atrial fibrillation includes the step of positioning a distal portion of an ablation instrument in proximity to one or more pulmonary veins. The instrument has a hollow housing and an independently axially positionable energy emitter within the distal portion The energy emitter is configured and the distal portion is shaped such that a distance a beam of ablative energy travels from the energy emitter to the portion of the distal portion in contact with target tissue changes based on the energy emitter's location along the length of the instrument while the distal portion maintains its shape The energy emitter is a light emitting element and a beam-forming optical waveguide that receives light from the light emitting element. The waveguide projects onto the distal portion a hollow cone of radiation.

Claims (25)

1. A method of treating atrial fibrillation, comprising:

positioning a distal portion of an ablation instrument in proximity to one or more pulmonary veins, the ablation instrument having a hollow housing and an independently axially positionable energy emitter within the distal portion, the distal portion being transmissive to radiant energy, wherein the energy emitter is configured and the distal portion is shaped such that a distance a beam of ablative energy travels from the energy emitter to the portion of the distal portion in contact with target tissue changes based on the energy emitter's location along the length of the ablation instrument while the distal portion maintains its shape, wherein the energy emitter comprises a light emitting element and a beam-forming optical waveguide that receives light from the light emitting element, wherein the wavequide is located at a distal end of the light emitting element and is configured so as to project onto the distal portion a hollow cone of radiation;

axially positioning the energy emitter at any of a plurality of locations along a length of distal portion;

activating the energy emitter to transmit energy to the waveguide located at the distal end of the light emitting element;

wherein the waveguide causes the transmitted energy to be confined to an annular band of light energy that is focused on the target tissue region; and

conveying the annular band of light energy through the distal portion of the housing to form an annular lesion in proximity to the one or more pulmonary veins.

2. The method of claim 1 wherein the method further comprises inflating a projection balloon to clear blood from a transmission pathway between the energy emitter and a target region of cardiac tissue.

3. The method of claim 2 wherein the method further comprises determining whether a clear transmission path exists between the energy emitter and the target region based on reflectance measurements by an optical sensor disposed within the ablation instrument.

4. The method of claim 3 wherein the method further comprises measuring at least two different wavelengths of reflected light collected by the optical sensor to determine whether a projection path has been established.

5. The method of claim 1 wherein the step of activating the energy emitter further comprises activating the light emitting element to expose the target regions to light energy to induce photocoagulation of cardiac tissue within the target region.

6. The method of claim 1 , wherein the light emitting element generates photoablative radiation at a desired wavelength ranging from about 800 nm to about 1000 nm.

7. The method of claim 1 , wherein the light emitting element generates photoablative radiation at a desired wavelength ranging from about 915 nm to about 980 nm.

8. The method of claim 1 , wherein the step of axially positioning includes the step of adjusting the position of the energy emitter until the energy emitter achieves a position where energy transmitted therefrom will contact a section of the distal portion that is in full circumferential contact with the target tissue region.

9. A method of treating atrial fibrillation, comprising:

selecting a target tissue region proximate to one or more pulmonary veins;

providing an ablation instrument that includes a catheter and a projection balloon coupled to the catheter, the ablation instrument having an independently axially positionable energy emitter within the projection balloon, the projection balloon being transmissive to radiant energy, the energy emitter being centrally located within an inner catheter that passes through the balloon;

positioning the projection balloon of the ablation instrument in proximity to the one or more pulmonary veins such that the projection balloon is seated against an ostium of the pulmonary vein and a distal end of the balloon is disposed at least partially within the pulmonary vein and a portion of the ablation instrument is in a heart chamber;

determining a location at which the projection balloon is in full circumferential contact with the ostium of the pulmonary vein;

axially positioning the energy emitter, while the projection balloon remains seated at the location, at a position along a length of the projection balloon in which the energy transmitted therefrom will contact a section of the projection balloon that is in full circumferential contact with the target tissue region; and

activating the energy emitter to transmit energy through the projection balloon to cause an annular band of energy, having a projection angle of between about 20 degrees to about 45 degrees, to be focused on the target tissue region to form an annular lesion in proximity to the one or more pulmonary veins.

10. The method of claim 9 , further including, prior to the step of activating the energy emitter, the step of determining whether a clear transmission path exists between the energy emitter and the target region based on reflectance measurements by an optical sensor disposed within the ablation instrument.

11. The method of claim 9 , wherein the step of determining the location at which the projection balloon is in full circumferential contact comprises the step of using reflectance measurements obtained by an optical sensor to determine if the projection balloon is in contact with the target tissue region.

12. The method of claim 9 , wherein a portion of the projection balloon that is seated against the ostium is free of any support by the catheter that terminates at a proximal end of the balloon.

13. The method of claim 9 , wherein the step of activating the energy emitter further comprises activating a radiation emitting element to expose the target region to at least one form of radiant energy selected from the group consisting of light, ultrasound, microwave, x-ray, gamma-ray and ionizing radiation to induce photocoagulation of cardiac tissue within a target region.

14. The method of claim 9 , wherein the projection balloon includes a distal neck portion that terminates in the distal end of the balloon, the distal neck portion being at least partially disposed within the pulmonary vein while a more proximal portion of the balloon that has a greater diameter when inflated lies outside the vein and at least partially in contact with the ostium.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded May 16, 2019
From: GPB DEBT HOLDINGS II, LLC
To: CARDIOFOCUS, INC.
Reel/Frame 049200/0597 →
RELEASE OF SECURITY INTEREST Recorded May 10, 2019
From: SILICON VALLEY BANK; OXFORD FINANCE LLC
To: CARDIOFOCUS, INC.
Reel/Frame 049138/0233 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 10, 2019
From: CARDIOFOCUS, INC.
To: KENNEDY LEWIS INVESTMENT MANAGEMENT LLC
Reel/Frame 049149/0356 →
RELEASE OF SECURITY INTEREST Recorded May 10, 2019
From: SILICON VALLEY BANK; SOLAR CAPITAL LTD.
To: CARDIOFOCUS, INC.
Reel/Frame 049138/0362 →
RELEASE OF SECURITY INTEREST Recorded May 9, 2019
From: SILICON VALLEY BANK; OXFORD FINANCE LLC
To: CARDIOFOCUS, INC.
Reel/Frame 049133/0474 →
SECURITY INTEREST Recorded Apr 9, 2018
From: CARDIOFOCUS, INC.
To: GPB DEBT HOLDINGS II LLC
Reel/Frame 045478/0532 →
SECURITY INTEREST Recorded Mar 31, 2017
From: CARDIOFOCUS, INC.
To: SILICON VALLEY BANK; SOLAR CAPITAL LTD.
Reel/Frame 041805/0976 →
SECURITY AGREEMENT Recorded Apr 24, 2015
From: CARDIOFOCUS, INC.
To: SILICON VALLEY BANK; OXFORD FINANCE LLC
Reel/Frame 035497/0393 →
SECURITY INTEREST Recorded Jul 31, 2014
From: CARDIOFOCUS, INC.
To: SILICON VALLEY BANK; OXFORD FINANCE LLC
Reel/Frame 033434/0399 →
Continuity (10)
Division 10357156 · Feb 3, 2003
Continuation In Part 09924394 · Aug 7, 2001
Continuation In Part 09390964 · Sep 7, 1999
Continuation In Part 08991130 · Dec 16, 1997
Continuation In Part 08827631 · Apr 10, 1997
Continuation 08303605 · Sep 9, 1994
Continuation In Part 09616275 · Jul 14, 2000
Continuation In Part 09602420 · Jun 23, 2000
Continuation In Part 09357355 · Jul 14, 1999
Related Publication 20060253113A1 · Nov 9, 2006